Monosodium glutamate (MSG): A villain and promoter of liver inflammation and dysplasia
Yuko Nakanishi(University of Toyama), M. Eric Gershwin(University of California, Davis), Masaki Aburada(Musashino University), Thucydides L. Salunga(Gifu University), Seiichi Iizuka(Musashino University), Kazuhiro Nomoto, Masayuki Nakano(Nihon University), Makoto Fujimoto(University of Toyama), Tsutomu Shimada(Kanazawa University), Wataru Suzuki(Musashino University), Jun-Ling An(University of Toyama), Yasuo Takano(Nihon University), Carlo Selmi(University of Milan), Mitsunobu Nagata(Musashino University), Koichi Tsuneyama(Tokushima University)
Cited by 151
Related Papers
Imaging Study of Early Hepatocellular Carcinoma: Usefulness of Gadoxetic Acid–enhanced MR Imaging
|Radiology|2011|354
cHCC‐CCA
|Hepatology|2018|333
Catalytic properties of polymorphic human cytochrome P450 1B1 variants
|Carcinogenesis|1999|274
Clinical aspects of intrahepatic bile duct carcinoma including hilar carcinoma.A study of 57 autopsy-proven cases
|Cancer|1977|262
Perivenular Fibrosis in Alcoholic Liver Injury: Ultrastructure and Histologic Progression
|Gastroenterology|1982|249